Ceryvyn Therapeutics Ltd. (CYVNY)
0.0232
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
Ceryvyn Therapeutics Market Cap : 3.967M for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 3.967M |
| September 16, 2026 | 3.933M |
| September 15, 2026 | 3.933M |
| September 14, 2026 | 3.933M |
| September 11, 2026 | 3.933M |
| September 10, 2026 | 3.933M |
| September 09, 2026 | 3.779M |
| September 08, 2026 | 3.779M |
| September 04, 2026 | 5.814M |
| September 03, 2026 | 3.967M |
| September 02, 2026 | 3.967M |
| September 01, 2026 | 3.420M |
| August 31, 2026 | 3.967M |
| August 28, 2026 | 3.967M |
| August 27, 2026 | 3.967M |
| August 26, 2026 | 3.967M |
| August 25, 2026 | 3.967M |
| August 24, 2026 | 3.762M |
| August 21, 2026 | 3.762M |
| August 20, 2026 | 3.762M |
| August 19, 2026 | 3.762M |
| August 18, 2026 | 3.762M |
| August 17, 2026 | 3.762M |
| August 14, 2026 | 3.762M |
| August 13, 2026 | 3.762M |
| Date | Value |
|---|---|
| August 12, 2026 | 5.130M |
| August 11, 2026 | 5.130M |
| August 10, 2026 | 4.788M |
| August 07, 2026 | 3.762M |
| August 06, 2026 | 3.779M |
| August 05, 2026 | 3.762M |
| August 04, 2026 | 4.668M |
| August 03, 2026 | 4.668M |
| July 31, 2026 | 4.463M |
| July 30, 2026 | 4.446M |
| July 29, 2026 | 4.446M |
| July 28, 2026 | 4.788M |
| July 27, 2026 | 3.762M |
| July 24, 2026 | 5.814M |
| July 23, 2026 | 5.814M |
| July 22, 2026 | 5.814M |
| July 21, 2026 | 4.788M |
| July 20, 2026 | 3.762M |
| July 17, 2026 | 2.941M |
| July 16, 2026 | 2.941M |
| July 15, 2026 | 5.814M |
| July 14, 2026 | 3.654M |
| July 13, 2026 | 4.591M |
| July 10, 2026 | 4.608M |
| July 09, 2026 | 4.608M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immutep Ltd. | 46.70M |
| CSL Ltd. | 60.78B |
| Propanc Biopharma, Inc. | 0.5509M |
| Mesoblast Ltd. | 1.928B |
| Actinogen Medical Ltd. | 115.59M |
Market Cap Related Metrics
| PE Ratio | 0.0179 |
| PS Ratio | 5592.63 |
| Price | 0.0232 |
| Earnings Yield | 5.60K% |
| Normalized PE Ratio | 0.0737 |